Registration of New Shares
Faron Pharmaceuticals Ltd. has approved the exercise of 3,366,377 Special Rights, resulting in the issuance of 3,366,377 new shares for an aggregate subscription price of EUR 1,596,000. These new shares have been registered, bringing the total ordinary shares to 206,411,888, with 3,530,573 held in treasury. Following a separate announcement regarding the issuance of 21,469,427 treasury shares expected around June 10, 2026, the total number of shares will be 227,881,315, with 25,000,000 in treasury. Trading of the newly issued shares is anticipated to commence on AIM and First North on or around June 4, 2026.
Select text to share a quote on X · sign in to keep highlights & notes in your FARN notes
| Faron Pharmaceuticals Ltd | Company announcement | June 03, 2026 at 14:00:00 EEST |
Capitalised terms used in this announcement have the meanings given to them in the announcement made on 3 June 2026 at 09:00 EEST regarding the amortisation payment and approval of share subscriptions based on special rights, unless the context provides otherwise.
Turku, Finland – Faron Pharmaceuticals Ltd. (AIM: FARN, First North: FARON), a clinical-stage biopharmaceutical company developing novel immunotherapies, has, as announced today on 3 June 2026, approved the exercise of 3,366,377 Special Rights entitling to 3,366,377 new Shares, for an aggregate subscription price of EUR 1,596,000.
In total, 3,366,377 new Shares in the Company have today on 3 June 2026 been registered in the Finnish Trade Register. The Shares rank pari passu in all respects with the existing shares of the Company. Following the registration of new Shares, the aggregate number of ordinary shares in the Company is 206,411,888 and of these shares, the Company holds 3,530,573 shares in treasury. The shares held in treasury by the Company do not confer a right to dividends or other shareholder rights. The Company announced on 28 May 2026 that it had issued 21,469,427 treasury shares to the Company itself and expects these shares to be registered on or around 10 June 2026. Once these shares are registered, the total number of shares in the Company will be 227,881,315, of which the Company then holds 25,000,000 shares in treasury.
Trading in the new Shares is expected to commence on First North and AIM on or around 4 June 2026.
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.